Abstract B143: Distinct antitumor mechanisms of VEGFR inhibitor tivozanib (AV-951) and mTOR inhibitor rapamycin support rational combination for solid tumors to overcome drug resistance
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.